Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective pressure mediated by influenza virus M158-66 epitope-specific CD8+T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells.
Jansen JM, Meineke R, Molle A, van de Sandt CE, Saletti G, Rimmelzwaan GF. Jansen JM, et al. Among authors: rimmelzwaan gf. Virus Res. 2024 May;343:199355. doi: 10.1016/j.virusres.2024.199355. Epub 2024 Mar 15. Virus Res. 2024. PMID: 38490580 Free PMC article.
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.
Oosting SF, van der Veldt AAM, Fehrmann RSN, Bhattacharya A, van Binnendijk RS, GeurtsvanKessel CH, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, de Wilt F, Ernst SM, Boerma A, van Zijl L, Rimmelzwaan GF, Kvistborg P, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. Oosting SF, et al. Among authors: rimmelzwaan gf. ESMO Open. 2023 Aug;8(4):101599. doi: 10.1016/j.esmoop.2023.101599. Epub 2023 Jun 21. ESMO Open. 2023. PMID: 37450950 Free PMC article. No abstract available.
Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.
Waldock J, Cox RJ, Engelhardt OG, Ascough S, Osterhaus A, Rimmelzwaan GF, Ludlow M, Tregoning JS, McDonald JU, Buchholz UJ, Jeeninga RE, Sande C, Chiu C. Waldock J, et al. Among authors: rimmelzwaan gf. Influenza Other Respir Viruses. 2024 Oct;18(10):e70013. doi: 10.1111/irv.70013. Influenza Other Respir Viruses. 2024. PMID: 39440808 Free PMC article. Review.
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity.
Aregay A, Slunečko J, Bogovic P, Korva M, Resman Rus K, Knap N, Beicht J, Kubinski M, Saletti G, Steffen I, Strle F, Avšič-Županc T, Osterhaus ADME, Rimmelzwaan GF. Aregay A, et al. Among authors: rimmelzwaan gf. Emerg Microbes Infect. 2024 Dec;13(1):2317909. doi: 10.1080/22221751.2024.2317909. Epub 2024 Feb 21. Emerg Microbes Infect. 2024. PMID: 39133062 Free PMC article.
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins.
Aregay A, Slunečko J, Korva M, Bogovic P, Resman Rus K, Knap N, Beicht J, Kubinski M, Saletti G, Avšič-Županc T, Steffen I, Strle F, Osterhaus ADME, Rimmelzwaan GF. Aregay A, et al. Among authors: rimmelzwaan gf. NPJ Vaccines. 2024 Aug 7;9(1):141. doi: 10.1038/s41541-024-00936-7. NPJ Vaccines. 2024. PMID: 39112523 Free PMC article.
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial.
Leroux-Roels I, Prajeeth CK, Aregay A, Nair N, Rimmelzwaan GF, Osterhaus ADME, Kardinahl S, Pelz S, Bauer S, D'Onofrio V, Alhatemi A, Jacobs B, De Boever F, Porrez S, Waerlop G, Punt C, Hendriks B, von Mauw E, van de Water S, Harders-Westerveen J, Rockx B, van Keulen L, Kortekaas J, Leroux-Roels G, Wichgers Schreur PJ. Leroux-Roels I, et al. Among authors: rimmelzwaan gf. Lancet Infect Dis. 2024 Nov;24(11):1245-1253. doi: 10.1016/S1473-3099(24)00375-X. Epub 2024 Jul 25. Lancet Infect Dis. 2024. PMID: 39068957 Clinical Trial.
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
Prajeeth CK, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, Beicht J, Kubinski M, Puff C, Baumgärtner W, Kortekaas J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF. Prajeeth CK, et al. Among authors: rimmelzwaan gf. Emerg Microbes Infect. 2024 Dec;13(1):2373313. doi: 10.1080/22221751.2024.2373313. Epub 2024 Jul 10. Emerg Microbes Infect. 2024. PMID: 38946528 Free PMC article.
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
Kubinski M, Beicht J, Gerlach T, Aregay A, Osterhaus ADME, Tscherne A, Sutter G, Prajeeth CK, Rimmelzwaan GF. Kubinski M, et al. Among authors: rimmelzwaan gf. Vaccines (Basel). 2024 Jan 20;12(1):105. doi: 10.3390/vaccines12010105. Vaccines (Basel). 2024. PMID: 38276677 Free PMC article.
358 results